Cargando…

P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.

Detalles Bibliográficos
Autores principales: Shaw, B., Shortt, J., Rogers, B., Kaplan, Z., Low, M., Gregory, G., Vilcassim, S., Grigoriadis, G., Fedele, P., Gilbertson, M., Opat, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430092/
http://dx.doi.org/10.1097/01.HS9.0000849292.48769.8c
_version_ 1784779653976686592
author Shaw, B.
Shortt, J.
Rogers, B.
Kaplan, Z.
Low, M.
Gregory, G.
Vilcassim, S.
Grigoriadis, G.
Fedele, P.
Gilbertson, M.
Opat, S.
author_facet Shaw, B.
Shortt, J.
Rogers, B.
Kaplan, Z.
Low, M.
Gregory, G.
Vilcassim, S.
Grigoriadis, G.
Fedele, P.
Gilbertson, M.
Opat, S.
author_sort Shaw, B.
collection PubMed
description
format Online
Article
Text
id pubmed-9430092
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94300922022-08-31 P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2. Shaw, B. Shortt, J. Rogers, B. Kaplan, Z. Low, M. Gregory, G. Vilcassim, S. Grigoriadis, G. Fedele, P. Gilbertson, M. Opat, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430092/ http://dx.doi.org/10.1097/01.HS9.0000849292.48769.8c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Shaw, B.
Shortt, J.
Rogers, B.
Kaplan, Z.
Low, M.
Gregory, G.
Vilcassim, S.
Grigoriadis, G.
Fedele, P.
Gilbertson, M.
Opat, S.
P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
title P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
title_full P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
title_fullStr P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
title_full_unstemmed P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
title_short P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
title_sort p1609: very low mortality in double vaccinated immunocompromised haematology patients infected with sars-cov-2.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430092/
http://dx.doi.org/10.1097/01.HS9.0000849292.48769.8c
work_keys_str_mv AT shawb p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT shorttj p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT rogersb p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT kaplanz p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT lowm p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT gregoryg p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT vilcassims p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT grigoriadisg p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT fedelep p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT gilbertsonm p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2
AT opats p1609verylowmortalityindoublevaccinatedimmunocompromisedhaematologypatientsinfectedwithsarscov2